New Jersey officials, health providers, and advocates all know it will be critical to improve the state's healthcare delivery through Accountable Care Organizations (ACOs) in order to reach its economically challenged communities. At a recent conference, Dr. Jeffrey Brenner, founder and executive director of the Camden Coalition of Healthcare Providers, said that the current models of healthcare delivery must change to be more successful. NJ Spotlight reports:
It will take a major effort by state officials, health providers and advocates to improve coordination and delivery of healthcare in some of the state’s most economically challenged communities, health leaders said yesterday.
But if that effort is successful, it could have implications for the entire country, according to participants in a conference attended by about 160 healthcare experts.
The conference focused on the launch of Medicaid accountable care organizations (ACOs) next year. In ACOs, healthcare providers are paid based on patient outcomes and their record of keeping costs down rather than for each service they provide.
“The service delivery models inside specialty care and primary care need to be completely and totally revamped,” said Dr. Jeffrey Brenner, founder and executive director of the Camden Coalition of Healthcare Providers. “When we’re done, they won’t look anything like they do now.”
Read the full story here: http://bit.ly/14cR4Jh
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More